BRAIN Biotech Stock | BNN.DE | DE0005203947 | 520394

Date	BRAIN Biotech Price
1/28/2025	3.22 undefined
1/27/2025	3.18 undefined
1/24/2025	3.26 undefined
1/23/2025	3.24 undefined
1/22/2025	3.26 undefined
1/21/2025	3.26 undefined
1/20/2025	3.27 undefined
1/17/2025	3.31 undefined
1/16/2025	3.25 undefined
1/15/2025	3.29 undefined
1/14/2025	3.57 undefined
1/13/2025	3.54 undefined
1/10/2025	3.48 undefined
1/9/2025	3.49 undefined
1/8/2025	3.50 undefined
1/7/2025	3.60 undefined
1/6/2025	3.45 undefined
1/3/2025	3.47 undefined
1/2/2025	3.50 undefined

Date	BRAIN Biotech Revenue	BRAIN Biotech EBIT	BRAIN Biotech Net Income
2030e	78.69 M undefined	0 undefined	0 undefined
2029e	74.73 M undefined	6.01 M undefined	0 undefined
2028e	78.34 M undefined	6.16 M undefined	8.79 M undefined
2027e	72.86 M undefined	11.15 M undefined	-772,397.46 undefined
2026e	72.52 M undefined	2.06 M undefined	1.38 M undefined
2025e	65.47 M undefined	780,225 undefined	-441,369.98 undefined
2024e	58.19 M undefined	-1.73 M undefined	-6.29 M undefined
2023	56.23 M undefined	-3.42 M undefined	-8.28 M undefined
2022	50.3 M undefined	-5.94 M undefined	-6.59 M undefined
2021	39.22 M undefined	-7.06 M undefined	-4.97 M undefined
2020	39.06 M undefined	-6.84 M undefined	-9.68 M undefined
2019	40.05 M undefined	-4.82 M undefined	-11.1 M undefined
2018	29.05 M undefined	-7.96 M undefined	-7.92 M undefined
2017	26.42 M undefined	-8.17 M undefined	-9.61 M undefined
2016	25.04 M undefined	-11.68 M undefined	-14.69 M undefined
2015	23.92 M undefined	-5.13 M undefined	-5.71 M undefined
2014	12.99 M undefined	-4.86 M undefined	-5.3 M undefined
2013	9.49 M undefined	-4.39 M undefined	-4.1 M undefined
2012	7.27 M undefined	-5.68 M undefined	-5.54 M undefined

	Revenue	EBIT	Net Income
2012	7.27 M EUR	-5.68 M EUR	-5.54 M EUR
2013	9.49 M EUR	-4.39 M EUR	-4.1 M EUR
2014	12.99 M EUR	-4.86 M EUR	-5.3 M EUR
2015	23.92 M EUR	-5.13 M EUR	-5.71 M EUR
2016	25.04 M EUR	-11.68 M EUR	-14.69 M EUR
2017	26.42 M EUR	-8.17 M EUR	-9.61 M EUR
2018	29.05 M EUR	-7.96 M EUR	-7.92 M EUR
2019	40.05 M EUR	-4.82 M EUR	-11.1 M EUR
2020	39.06 M EUR	-6.84 M EUR	-9.68 M EUR
2021	39.22 M EUR	-7.06 M EUR	-4.97 M EUR
2022	50.3 M EUR	-5.94 M EUR	-6.59 M EUR
2023	56.23 M EUR	-3.42 M EUR	-8.28 M EUR
2024e	58.19 M EUR	-1.73 M EUR	-6.29 M EUR
2025e	65.47 M EUR	780,225 EUR	-441,369.98 EUR
2026e	72.52 M EUR	2.06 M EUR	1.38 M EUR
2027e	72.86 M EUR	11.15 M EUR	-772,397.46 EUR
2028e	78.34 M EUR	6.16 M EUR	8.79 M EUR
2029e	74.73 M EUR	6.01 M EUR	0 EUR
2030e	78.69 M EUR	0 EUR	0 EUR

2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024e	2025e	2026e	2027e	2028e	2029e	2030e
7	9	12	23	25	26	29	40	39	39	50	56	58	65	72	72	78	74	78
-	28.57	33.33	91.67	8.70	4.00	11.54	37.93	-2.50	-	28.21	12.00	3.57	12.07	10.77	-	8.33	-5.13	5.41
42.86	55.56	66.67	52.17	52.00	57.69	51.72	55.00	56.41	56.41	56.00	55.36	53.45	47.69	43.06	43.06	39.74	41.89	39.74
3	5	8	12	13	15	15	22	22	22	28	31	0	0	0	0	0	0	0
-5	-4	-5	-5	-14	-9	-7	-11	-9	-4	-6	-8	-6	0	1	0	8	0	0
-	-20.00	25.00	-	180.00	-35.71	-22.22	57.14	-18.18	-55.56	50.00	33.33	-25.00	-	-	-	-	-	-
11.45	11.66	12.73	12.73	15.13	16.49	18.06	18.06	18.66	19.94	21.85	21.85	0	0	0	0	0	0	0
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023

6.78	11.26	4.46	3.48	18.66	39.25	25.8	15.22	19.05	24.65	8.81	5.41
1.28	1.54	2.41	2.74	2.77	3.95	5.49	5.6	5.9	6.47	7.42	8.84
0.16	0.11	0.4	1.49	3.18	2.68	1.1	1.11	0.67	0.48	3.92	1
2.05	2.05	4.57	6.52	7.13	7.24	8.04	8.03	6.96	7.02	9.66	9.76
280	350	320	850.47	264.19	429	595	997	507	496	573	479
10.55	15.31	12.16	15.07	32	53.56	41.02	30.96	33.08	39.11	30.38	25.48
6.78	6.73	6.88	6.88	7.09	7.59	12.04	17.14	24.47	24.29	28.74	28.72
0.2	0.71	0.16	0	0.17	0.17	1.98	1.44	1	0.55	1.94	1.46
0	0	0	25	41	16	80	558	200	150	100	50
2.19	2.29	5.88	5.22	4.93	4.42	12.71	11.21	8.79	8.81	10.16	8.55
0	0	0	2.82	2.82	2.67	6.37	4.59	4.48	4.73	6.61	6.67
0	60	210	398.5	459.17	88	267	232	129	101	69	20
9.17	9.79	13.13	15.34	15.51	14.95	33.45	35.17	39.07	38.62	47.61	45.46
19.72	25.1	25.29	30.41	47.51	68.5	74.46	66.12	72.15	77.74	77.99	70.94

11.45	12.73	12.73	12.73	16.41	18.06	18.06	18.06	19.86	21.85	21.85	21.85
0	0	0	0	0	0	0	65.17	78.39	95.89	92.66	93.46
-0.04	4.57	-0.73	-7.28	10.27	29.12	5.47	-67.92	-77.5	-79.51	-85.2	-94.16
0	0	0	0	0	0	-1	8	35	556	328	627
0	0	0	0	0	0	0	0	0	0	0	0
11.41	17.3	12	5.45	26.68	47.18	23.53	15.32	20.79	38.78	29.64	21.77
0.83	1.12	1.35	3.08	2.86	2.43	2.87	4.43	3.17	3.83	6.75	5.62
0	0	0	0	0	0	0	1.15	3.02	1.92	2.23	3
1.56	1.4	1.79	2.54	4.1	4.48	5.66	7.33	3.84	3.27	9.7	5.17
0	0	0	0	0	0	0	0	0	0	0	0
0.25	1.04	2.15	2.11	3.45	1.51	2.44	1.96	2.33	2.32	2.71	3.7
2.64	3.56	5.29	7.73	10.41	8.42	10.97	14.87	12.36	11.34	21.39	17.48
4.6	3.89	7.17	14.25	6.24	8.18	25.35	5.38	10.76	9.06	8.03	17.8
0.14	0.01	0.66	1.44	1.26	1.14	2.89	2.59	2.16	2.79	3.29	3.77
0.21	0.04	0.03	1.23	2.67	3.39	6.84	23.11	20.74	12.72	11.03	8.88
4.95	3.94	7.86	16.92	10.17	12.72	35.08	31.08	33.65	24.57	22.36	30.45
7.59	7.5	13.15	24.65	20.59	21.14	46.05	45.95	46.01	35.91	43.74	47.92
19	24.8	25.15	30.1	47.27	68.32	69.58	61.27	66.79	74.69	73.38	69.69

2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
-5	-4	-5	-5	-14	-9	-8	-10	-9	-4	-6	-8
0	0	1	1	1	1	3	4	4	4	4	4
0	0	0	0	0	0	0	0	0	0	0	0
0	0	0	0	0	0	3	2	1	1	3	0
0	0	0	0	3	1	-3	0	0	-4	-3	-1
0	0	0	0	0	0	0	0	0	0	0	0
0	0	0	0	0	0	0	0	0	0	0	0
-5	-4	-3	-4	-8	-5	-5	-3	-4	-3	-1	-4
0	0	-1	0	-1	-1	-1	-6	-2	-1	-6	-2
4	1	-1	0	-11	8	-12	-6	-4	-2	-12	0
5	2	0	0	-9	9	-11	0	-1	0	-6	3
0	0	0	0	0	0	0	0	0	0	0	0
0	0	0	3	-5	0	4	0	-1	-2	-1	10
0	9	0	0	0	0	0	0	0	0	0	0
0	10	0	3	24	27	4	0	13	11	-1	0
0	0	0	0	30	28	0	0	14	14	0	-9
0	0	0	0	0	0	0	0	0	0	0	0
0	6	-4	-1	5	30	-13	-10	3	5	-16	-3
-6.26	-5.57	-4.95	-4.71	-9.91	-6.84	-6.76	-10.02	-7.63	-5.17	-7.57	-6.86
0	0	0	0	0	0	0	0	0	0	0	0

BRAIN Biotech Gross margin	BRAIN Biotech Profit margin	BRAIN Biotech EBIT margin	BRAIN Biotech Profit margin
2030e	55.16 %	0 %	0 %
2029e	55.16 %	8.04 %	0 %
2028e	55.16 %	7.86 %	11.23 %
2027e	55.16 %	15.31 %	-1.06 %
2026e	55.16 %	2.84 %	1.9 %
2025e	55.16 %	1.19 %	-0.67 %
2024e	55.16 %	-2.97 %	-10.81 %
2023	55.16 %	-6.09 %	-14.72 %
2022	56.13 %	-11.81 %	-13.1 %
2021	57.12 %	-18 %	-12.68 %
2020	56.42 %	-17.5 %	-24.79 %
2019	56.44 %	-12.03 %	-27.72 %
2018	52.98 %	-27.41 %	-27.25 %
2017	57 %	-30.93 %	-36.37 %
2016	54.39 %	-46.63 %	-58.67 %
2015	54.07 %	-21.45 %	-23.89 %
2014	63.13 %	-37.41 %	-40.8 %
2013	56.59 %	-46.26 %	-43.2 %
2012	46.49 %	-78.13 %	-76.2 %

	Gross margin	EBIT margin	Profit margin
2012	46.49 %	-78.13 %	-76.2 %
2013	56.59 %	-46.26 %	-43.2 %
2014	63.13 %	-37.41 %	-40.8 %
2015	54.07 %	-21.45 %	-23.89 %
2016	54.39 %	-46.63 %	-58.67 %
2017	57 %	-30.93 %	-36.37 %
2018	52.98 %	-27.41 %	-27.25 %
2019	56.44 %	-12.03 %	-27.72 %
2020	56.42 %	-17.5 %	-24.79 %
2021	57.12 %	-18 %	-12.68 %
2022	56.13 %	-11.81 %	-13.1 %
2023	55.16 %	-6.09 %	-14.72 %
2024e	55.16 %	-2.97 %	-10.81 %
2025e	55.16 %	1.19 %	-0.67 %
2026e	55.16 %	2.84 %	1.9 %
2027e	55.16 %	15.31 %	-1.06 %
2028e	55.16 %	7.86 %	11.23 %
2029e	55.16 %	8.04 %	0 %
2030e	55.16 %	0 %	0 %

Date	BRAIN Biotech Sales per Share	BRAIN Biotech EBIT per share	BRAIN Biotech Earnings per Share
2030e	3.6 undefined	0 undefined	0 undefined
2029e	3.42 undefined	0 undefined	0 undefined
2028e	3.59 undefined	0 undefined	0.4 undefined
2027e	3.33 undefined	0 undefined	-0.04 undefined
2026e	3.32 undefined	0 undefined	0.06 undefined
2025e	3 undefined	0 undefined	-0.02 undefined
2024e	2.66 undefined	0 undefined	-0.29 undefined
2023	2.57 undefined	-0.16 undefined	-0.38 undefined
2022	2.3 undefined	-0.27 undefined	-0.3 undefined
2021	1.97 undefined	-0.35 undefined	-0.25 undefined
2020	2.09 undefined	-0.37 undefined	-0.52 undefined
2019	2.22 undefined	-0.27 undefined	-0.61 undefined
2018	1.61 undefined	-0.44 undefined	-0.44 undefined
2017	1.6 undefined	-0.5 undefined	-0.58 undefined
2016	1.65 undefined	-0.77 undefined	-0.97 undefined
2015	1.88 undefined	-0.4 undefined	-0.45 undefined
2014	1.02 undefined	-0.38 undefined	-0.42 undefined
2013	0.81 undefined	-0.38 undefined	-0.35 undefined
2012	0.63 undefined	-0.5 undefined	-0.48 undefined

	Sales per Share	EBIT per share	Earnings per Share
2012	0.63 EUR	-0.5 EUR	-0.48 EUR
2013	0.81 EUR	-0.38 EUR	-0.35 EUR
2014	1.02 EUR	-0.38 EUR	-0.42 EUR
2015	1.88 EUR	-0.4 EUR	-0.45 EUR
2016	1.65 EUR	-0.77 EUR	-0.97 EUR
2017	1.6 EUR	-0.5 EUR	-0.58 EUR
2018	1.61 EUR	-0.44 EUR	-0.44 EUR
2019	2.22 EUR	-0.27 EUR	-0.61 EUR
2020	2.09 EUR	-0.37 EUR	-0.52 EUR
2021	1.97 EUR	-0.35 EUR	-0.25 EUR
2022	2.3 EUR	-0.27 EUR	-0.3 EUR
2023	2.57 EUR	-0.16 EUR	-0.38 EUR
2024e	2.66 EUR	0 EUR	-0.29 EUR
2025e	3 EUR	0 EUR	-0.02 EUR
2026e	3.32 EUR	0 EUR	0.06 EUR
2027e	3.33 EUR	0 EUR	-0.04 EUR
2028e	3.59 EUR	0 EUR	0.4 EUR
2029e	3.42 EUR	0 EUR	0 EUR
2030e	3.6 EUR	0 EUR	0 EUR

	Number of stocks
2012	11.45 M Aktien
2013	11.66 M Aktien
2014	12.73 M Aktien
2015	12.73 M Aktien
2016	15.13 M Aktien
2017	16.49 M Aktien
2018	18.06 M Aktien
2019	18.06 M Aktien
2020	18.66 M Aktien
2021	19.94 M Aktien
2022	21.85 M Aktien
2023	21.85 M Aktien
2024e	21.85 M Aktien
2025e	21.85 M Aktien
2026e	21.85 M Aktien
2027e	21.85 M Aktien
2028e	21.85 M Aktien
2029e	21.85 M Aktien
2030e	21.85 M Aktien

Date	EPS Estimate	EPS Actual	Quarterly report
9/30/2016	-0.1	-0.15 (-48.51 %)	2016 Q4

%	Name	Stocks	Change	Date
45.39480 %	Putsch (Martin)	9,918,763	0	10/9/2024
6.89921 %	Founders and management of BRAIN Biotechnology Research and Information	1,507,477	0	10/9/2024
5.59936 %	Hopp (Daniel)	1,223,460	0	10/9/2024
4.98738 %	Universal-Investment-Gesellschaft mbH	1,089,743	0	10/9/2024
2.72311 %	Sachse (Gabriele)	595,000	595,000	10/23/2023
2.60407 %	Wydler Asset Management AG	568,989	-15,412	3/31/2024
2.25341 %	Medical Strategy GmbH	492,370	0	9/30/2023
1.79021 %	Deka Investment GmbH	391,161	0	6/30/2024
1.57985 %	Berenberg Bank (Asset Management)	345,197	0	3/31/2024
1.50748 %	MEAG Munich ERGO Kapitalanlagegesellschaft mbH	329,385	0	6/30/2024
1.46245 %	FPM Frankfurt Performance Management AG	319,546	0	7/31/2024
1.09234 %	Platinum Asset Management	238,676	-28,093	7/31/2024
1.01602 %	DWS Investment GmbH	222,000	0	8/31/2024
0.16476 %	Lupus alpha Asset Management AG	35,999	0	6/30/2024
0.08720 %	ESALIENS TFI SA	19,054	-10,946	12/31/2023
0.07856 %	Spirit Asset Management S.A.	17,166	0	6/30/2024
0.07780 %	KIRIX Vermögensverwaltung AG	17,000	0	9/30/2024
0.07689 %	SP Fund Management Company Ltd	16,800	0	8/31/2024
0.06284 %	Deka International S.A.	13,730	0	3/31/2024
0.04577 %	SMS & Cie. Vermögensmanagement GmbH	10,000	0	9/30/2024
0 %	Apo Asset Management GmbH	0	-21,977	2/29/2024
0 %	UBS Asset Management (Deutschland) GmbH	0	-23,500	5/31/2024
0 %	LBBW Asset Management Investmentgesellschaft mbH	0	-10,000	7/31/2023
0 %	Baring Asset Management Ltd.	0	-5,517	2/29/2024
0 %	LAIQON AG	0	-830,205	5/31/2023

Name	Relationship	Two-week correlation	One-month correlation	Three-Month Correlation	Six-Month Correlation	One Year Correlation	Two-Year Correlation
Merck	SupplierCustomer	0,65	0,52	0,54	0,47	0,22	0,60
Fuchs Petrolub Vz	SupplierCustomer	0,27	0,69	0,82	0,81	0,88	0,04
Koninklijke DSM	SupplierCustomer	0,23	0,74	0,76	0,57	0,51	0,64
General Mills	SupplierCustomer	0,20	-0,23	-0,61	-0,35	-0,76	-0,15
Suntory Beverage & Food	SupplierCustomer	0,16	-0,01	-0,83	-0,76	-0,63	0,11
Henkel Vz	SupplierCustomer	0,11	-0,15	0,28	0,76	0,81	-0,05
RWE	SupplierCustomer	0,06	-0,29	-0,60	-0,67	-0,80	-0,26
Bayer	SupplierCustomer	-0,02	0,66	-0,63	-0,73	-0,70	-0,26
Evonik Industries	SupplierCustomer	-0,04	-0,49	-0,19	0,68	0,68	0,73
BASF	SupplierCustomer	-0,11	0,32	0,62	0,74	0,76	0,68

What values and corporate philosophy does BRAIN Biotech represent?

BRAIN Biotechnology Research and Information Network AG represents core values of innovation, collaboration, and sustainable development in the biotechnology research and information sector. With a steadfast commitment to utilizing cutting-edge technology, BRAIN AG strives to revolutionize industries by harnessing the power of nature's vast biodiversity. By fostering strong partnerships and collaborations, BRAIN AG aims to provide novel solutions that address challenges in areas such as healthcare, nutrition, and consumer goods. With a focus on sustainability, BRAIN AG actively promotes environmentally friendly practices and the responsible use of resources. BRAIN AG's corporate philosophy revolves around unlocking the potential of nature and delivering value to its stakeholders through pioneering biotechnological research and information networks.

In which countries and regions is BRAIN Biotech primarily present?

BRAIN Biotechnology Research and Information Network AG primarily operates in Germany and has a strong presence in Europe.

What significant milestones has the company BRAIN Biotech achieved?

BRAIN Biotechnology Research and Information Network AG has achieved several significant milestones since its inception. The company has successfully established itself as a leading provider of innovative solutions in the field of biotechnology research and information. BRAIN AG has developed groundbreaking technologies and solutions that have revolutionized many industries, including pharmaceuticals, agriculture, and nutrition. The company's collaborative efforts with renowned partners have resulted in numerous successful research projects and product developments. Additionally, BRAIN AG has received prestigious recognition and awards for its outstanding contributions to the biotechnology sector. Overall, BRAIN Biotechnology Research and Information Network AG continues to make remarkable strides in advancing the boundaries of biotechnology innovation and research.

What is the history and background of the company BRAIN Biotech?

BRAIN Biotechnology Research and Information Network AG, commonly known as BRAIN AG, is a renowned company in the biotechnology sector. Established in 1993, BRAIN AG has a strong history of pioneering advancements in the field of industrial biotechnology. This German-based company specializes in the discovery and development of innovative bio-based products and solutions. With a focus on exploiting the vast potential of nature's biodiversity, BRAIN AG applies its unique BioArchive to identify novel enzymes, microorganisms, and natural substances for various industrial applications. Over the years, BRAIN AG has successfully collaborated with numerous industry partners, leading to groundbreaking innovations in areas such as agriculture, consumer goods, and pharmaceuticals. With its rich history and expertise, BRAIN AG continues to redefine the boundaries of biotechnological research and development.

Who are the main competitors of BRAIN Biotech in the market?

The main competitors of BRAIN Biotechnology Research and Information Network AG in the market include companies such as BASF SE, Novozymes A/S, and Codexis, Inc. These companies are also involved in the biotechnology and research sectors, offering innovative solutions and products. However, BRAIN AG differentiates itself through its comprehensive portfolio of bio-based products, cutting-edge technologies, and expertise in biotechnology, strand synthesis, and enzyme engineering. This allows BRAIN AG to offer customized and sustainable solutions for various industries, including food and nutrition, pharmaceuticals, and cosmetics.

In which industries is BRAIN Biotech primarily active?

BRAIN Biotechnology Research and Information Network AG is primarily active in the biotechnology industry.

What is the business model of BRAIN Biotech?

The business model of BRAIN Biotechnology Research and Information Network AG revolves around the development and commercialization of innovative solutions for the bio-based economy. BRAIN offers industrial partners access to a wide range of bioactive substances and enzymes derived from natural resources. The company utilizes its proprietary BioArchive and BioXtractor technologies to discover and optimize these valuable compounds. BRAIN then collaborates with various industries, including the chemical, pharmaceutical, and food sectors, to develop customized solutions for their specific needs. By leveraging its expertise in biotechnology and bioinformatics, BRAIN aims to contribute to sustainable and resource-efficient processes in industries worldwide.

What is the P/E ratio of BRAIN Biotech 2025?

The BRAIN Biotech P/E ratio is -159.39.

What is the P/S ratio of BRAIN Biotech 2025?

The BRAIN Biotech P/S ratio is 1.07.

What is the Quality Investing of BRAIN Biotech?

The Quality Investing for BRAIN Biotech is 4/10.

What is the revenue of BRAIN Biotech 2025?

The expected BRAIN Biotech revenue is 65.47 M EUR.

How high is the profit of BRAIN Biotech 2025?

The expected BRAIN Biotech profit is -441,369.98 EUR.

What is the business model of BRAIN Biotech

The BRAIN Biotechnology Research and Information Network AG specializes in the research and development of innovative biotechnological products. The company is divided into three different divisions: BioScience, BioIndustrial, and BioResources. The BioScience division focuses primarily on identifying and characterizing new active substances and enzymes from nature. BRAIN works closely with various global industrial companies to translate research findings into marketable products. The BioScience division is also responsible for conducting customized research projects tailored to the specific needs of the companies. BRAIN's BioIndustrial division focuses on the development and production of customized enzymes and microorganisms for industrial applications in various industries, such as food, paper, and textile. By using biotechnological processes, products can be produced in a more environmentally friendly manner and resources can be saved. BRAIN's BioResources division specializes in the use of biomass for the extraction of valuable raw materials. Sustainable and environmentally friendly methods are used to produce high-quality products such as bioenergy, biorefinery products, and biopolymers from biological waste and residues. BRAIN offers customers a comprehensive range of services in the field of biotechnological research and development. The company emphasizes a strong customer-oriented approach and close collaboration with industry partners. BRAIN has a large number of patents and market approvals that emphasize the high quality of its products. BRAIN's products include enzymes for the food industry for cheese and bread production, as well as specially adapted microorganisms for the production of bioethanol or biogas. In the cosmetics industry, BRAIN also offers innovative solutions such as natural active ingredients for skin and hair care products. In summary, BRAIN offers a wide range of biotechnological solutions for sustainable and efficient production in various industries. The close collaboration with industry partners allows for meeting individual customer needs and offering tailored solutions. BRAIN is an innovative company that is globally at the forefront of biotechnology due to its high level of research and development performance and the use of state-of-the-art technology. BRAIN specializes in the research and development of biotechnological products in various industries.

What is the BRAIN Biotech dividend?

BRAIN Biotech pays a dividend of 0 EUR distributed over payouts per year.

How often does BRAIN Biotech pay dividends?

The dividend cannot currently be calculated for BRAIN Biotech or the company does not pay out a dividend.

What is the BRAIN Biotech ISIN?

The ISIN of BRAIN Biotech is DE0005203947.

What is the BRAIN Biotech WKN?

The WKN of BRAIN Biotech is 520394.

What is the BRAIN Biotech ticker?

The ticker of BRAIN Biotech is BNN.DE.

How much dividend does BRAIN Biotech pay?

Over the past 12 months, BRAIN Biotech paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, BRAIN Biotech is expected to pay a dividend of 0 EUR.

What is the dividend yield of BRAIN Biotech?

The current dividend yield of BRAIN Biotech is .

When does BRAIN Biotech pay dividends?

BRAIN Biotech pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of BRAIN Biotech?

BRAIN Biotech paid dividends every year for the past 0 years.

What is the dividend of BRAIN Biotech?

For the upcoming 12 months, dividends amounting to 0 EUR are expected. This corresponds to a dividend yield of 0 %.

In which sector is BRAIN Biotech located?

BRAIN Biotech is assigned to the 'Commodities' sector.

Wann musste ich die Aktien von BRAIN Biotech kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of BRAIN Biotech from 1/29/2025 amounting to 0 EUR, you needed to have the stock in your portfolio before the ex-date on 1/29/2025.

When did BRAIN Biotech pay the last dividend?

The last dividend was paid out on 1/29/2025.

What was the dividend of BRAIN Biotech in the year 2024?

In the year 2024, BRAIN Biotech distributed 0 EUR as dividends.

In which currency does BRAIN Biotech pay out the dividend?

The dividends of BRAIN Biotech are distributed in EUR.

Stock Exchange	BRAIN Biotech Ticker
DÜSSELDORF	BNN.DU
FRANKFURT	BNN.F
HAMBURG	BNN.HM
LONDON	0RFI.L
MUNICH	BNN.MU
SIX	BNN.SW
XETRA	BNN.DE

BRAIN Biotech Ticker	BRAIN Biotech FIGI
BNN:GR	BBG000HC2617
BNN:GF	BBG00BT8SH71
BNN:GD	BBG00BT8SH80
BNN:GY	BBG00BT8SH99
BNN:GM	BBG00BT8SHC5
BNN:GB	BBG00BT8SHD4
BNN:TH	BBG00BZSHYG5
BNNEUR:EO	BBG00C04CD20
BNNEUR:XH	BBG00C04CD57
BNNEUR:XF	BBG00C04CD75
BNNEUR:XE	BBG00C04CD93
BNNEUR:XJ	BBG00C04CDB0
BNNEUR:XL	BBG00C04CDC9
BNNEUR:XG	BBG00C04CDD8
BNNEUR:XO	BBG00C04CDF6
BNNEUR:XP	BBG00C04CDH4
BNNEUR:XS	BBG00C04CDK0
BNNEUR:XA	BBG00C04CDL9
BNNEUR:E1	BBG00C04CDM8
BNNEUR:XT	BBG00C04CDN7
BNNEUR:XW	BBG00C04CDP5
BNNEUR:XU	BBG00C04CDQ4
BNNEUR:XV	BBG00C04CDR3
BNNEUR:EU	BBG00C04CDT1
BNN:QT	BBG00C66CTK4
BNND:PO	BBG00CNLDJZ7
BNND:L3	BBG00CNLDS05
BNND:B3	BBG00CNLDWW1
BNN:GZ	BBG00FGX78H3
BNNEUR:XX	BBG00JN81G35
BNN:TE	BBG00L31LBV5
BNN1GBX:XS	BBG00L8NC5D5
BNN1GBX:XH	BBG00L8NC5H1
BNN1GBX:XF	BBG00L8NC5K7
BNN1GBX:XE	BBG00L8NC5M5
BNN1GBX:XJ	BBG00L8NC5N4
BNN1GBX:XL	BBG00L8NC5P2
BNN1GBX:XG	BBG00L8NC5Q1
BNN1GBX:XO	BBG00L8NC5R0
BNN1GBX:XA	BBG00L8NC5W4
BNN1GBX:E1	BBG00L8NC5X3
BNN1GBX:XT	BBG00L8NC5Y2
BNN1GBX:XW	BBG00L8NC5Z1
BNN1GBX:XU	BBG00L8NC607
BNN1GBX:XV	BBG00L8NC616
BNN1GBX:XM	BBG00L8NC625
BNN1GBX:XQ	BBG00L8NC634
BNN1GBX:XX	BBG00L8NC643
BNN1GBX:XZ	BBG00L8NC652
BNN1GBX:EU	BBG00L8NC670
BNN:SW	BBG00LVDC5M1
BNN:BW	BBG00LVDC5T4
BNND:IX	BBG00MDLXCX1
BNND:EB	BBG00MDLYTJ9
BNND:I2	BBG00NQB8TJ4
0RFI:LN	BBG00NRVY799
BNND:S1	BBG00RN4NVW7
BNND:L1	BBG00Y7BHJ94
BNND:S4	BBG00YJ839Y7
BNN:LA	BBG018H8YZR1
BNN:LU	BBG018J2M0N6
BNN1USD:EO	BBG01F7JFNJ9
BNN1USD:X2	BBG01F7JFNK7
BNN1USD:XH	BBG01F7JFNM5
BNN1USD:XF	BBG01F7JFNP2
BNN1USD:XE	BBG01F7JFNR0
BNN1USD:XJ	BBG01F7JFNS9
BNN1USD:XL	BBG01F7JFNT8
BNN1USD:XG	BBG01F7JFNV5
BNN1USD:XO	BBG01F7JFNW4
BNN1USD:XA	BBG01F7JFP04
BNN1USD:E1	BBG01F7JFP13
BNN1USD:XT	BBG01F7JFP22
BNN1USD:XW	BBG01F7JFP31
BNN1USD:XU	BBG01F7JFP40
BNN1USD:XY	BBG01F7JFP59
BNN1USD:XV	BBG01F7JFP68
BNN1USD:XM	BBG01F7JFP77
BNN1USD:XQ	BBG01F7JFP86
BNN1USD:XX	BBG01F7JFP95
BNN1USD:XZ	BBG01F7JFPB2
BNN1USD:X1	BBG01F7JFPD0
BNN1USD:EU	BBG01F7JFPG7

Access the world's leading financial data and tools

Price

Price

TickerBNN.DE

ISINDE0005203947

WKN520394

BRAIN Biotech stock price

Price

Overview

Intraday Feature

Total Return and Relative Price Change

Interpretation and Investment

BRAIN Biotech Stock Price History

BRAIN Biotech Revenue, EBIT, Net Income DE0005203947 · 520394

Revenue, EBIT and Profit

Understanding Revenue, EBIT, and Income

Yearly Analysis and Comparisons

Utilizing Expectations for Investment

Investment Insights

BRAIN Biotech Revenue, EBIT and net profit per share

BRAIN Biotech Income Statement, Balance Sheet, Cash Flow Statement

Keystats

Revenue and Growth

Gross Margin

EBIT and EBIT Margin

Income and Growth

Shares Outstanding

Interpreting Year to Year Comparison

Expectations and Predictions

Balance Sheet

Understanding the Balance Sheet

Assets

Liabilities

Equity

Year-to-Year Analysis

Interpreting the Data

BRAIN Biotech stock margins DE0005203947 · 520394

Margin

Understanding Gross Margin

EBIT Margin Analysis

Revenue Margin Insights

Interpreting Expectations

Comparative Analysis

BRAIN Biotech Margin History

BRAIN Biotech Stock Sales Revenue, EBIT, Earnings per Share DE0005203947 · 520394

Revenue, EBIT and Earnings per share

Revenue Per Share

EBIT Per Share

Income Per Share

Expected Values

BRAIN Biotech Revenue, EBIT and net profit per share

BRAIN Biotech business model

BRAIN Biotech SWOT Analysis

Strengths

Weaknesses

Opportunities

Threats

The World’s Best Investors Are On Eulerpool

BRAIN Biotech Eulerpool Fair Value

Fair Value

Understanding Fair Value

Income-Based Fair Value

Revenue-Based Fair Value

Dividend-Based Fair Value

Expectations and Forecasts

Comparative Analysis

BRAIN Biotech historical P/E ratio, EBIT multiple, and P/S ratio

The World’s Best Investors Are On Eulerpool

BRAIN Biotech shares outstanding DE0005203947 · 520394

Revenue, EBIT and Earnings per share

Revenue Per Share

EBIT Per Share

Income Per Share

Expected Values

The World’s Best Investors Are On Eulerpool

BRAIN Biotech Earnings Estimates

BRAIN Biotech latest earnings and earnings surprises

BRAIN Biotech shareholders

BRAIN Biotech Executives and Management Board

Mr. Adriaan Moelker

Ticker
BNN.DE

ISIN
DE0005203947

WKN
520394